NANOVIRICIDES, INC. Property, Plant and Equipment, Gross
NANOVIRICIDES, INC. (NNVC) had Property, Plant and Equipment, Gross of $15.11 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-05-15
- 2026-03-31: Property, Plant and Equipment, Gross $15.11M.
- 2025-12-31: Property, Plant and Equipment, Gross $15.11M.
- 2025-09-30: Property, Plant and Equipment, Gross $15.11M.
- 2025-06-30: Property, Plant and Equipment, Gross $15.02M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-03-31 | $15.11M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $15.11M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $15.11M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $15.02M 10-Q · filed 2026-05-15 |
| 2025-03-31 | $15.01M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $15.01M 10-Q · filed 2025-02-14 |
| 2024-09-30 | $15.01M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $14.97M 10-K · filed 2025-09-29 |
| 2024-03-31 | $14.87M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $14.82M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $14.82M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $14.81M 10-K · filed 2024-09-27 |
| 2023-03-31 | $14.81M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $14.75M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $14.70M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $14.66M 10-K · filed 2023-10-13 |
| 2022-03-31 | $14.58M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $14.54M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $14.36M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $14.33M 10-K · filed 2022-10-13 |
| 2021-03-31 | $14.25M 10-Q · filed 2021-05-14 |
| 2020-09-30 | $14.14M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $14.10M 10-K · filed 2021-10-12 |
| 2020-03-31 | $14.10M 10-Q · filed 2020-06-22 |
| 2019-12-31 | $14.10M 10-Q · filed 2020-02-14 |
| 2019-09-30 | $14.10M 10-Q · filed 2019-11-15 |
| 2019-06-30 | $14.09M 10-K · filed 2020-10-13 |
| 2019-03-31 | $14.08M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $14.08M 10-Q · filed 2019-02-14 |
| 2018-09-30 | $14.06M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $14.02M 10-K · filed 2019-08-23 |
| 2018-03-31 | $14.00M 10-Q · filed 2018-05-21 |
| 2017-12-31 | $13.87M 10-Q · filed 2018-02-20 |
| 2017-09-30 | $13.81M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $13.78M 10-K · filed 2018-10-12 |
| 2017-03-31 | $13.73M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $13.64M 10-Q · filed 2017-02-14 |
| 2016-09-30 | $13.64M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $13.61M 10-K · filed 2017-09-28 |
| 2016-03-31 | $13.59M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $13.53M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $13.83M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $13.50M 10-K · filed 2016-09-16 |
| 2015-03-31 | $12.30M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $12.05M 10-Q · filed 2015-02-25 |
| 2014-09-30 | $7.30M 10-Q/A · filed 2015-02-23 |
| 2014-06-30 | $6.74M 10-K · filed 2015-09-14 |
| 2014-03-31 | $5.12M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $3.86M 10-Q · filed 2014-02-14 |
| 2013-09-30 | $3.78M 10-Q/A · filed 2015-02-23 |
| 2013-06-30 | $1.51M 10-K · filed 2015-02-23 |
| 2013-03-31 | $1.44M 10-Q/A · filed 2013-05-20 |
| 2012-12-31 | $1.44M 10-Q/A · filed 2013-02-22 |
| 2012-09-30 | $1.44M 10-Q · filed 2012-11-19 |
| 2012-06-30 | $1.44M 10-K/A · filed 2013-10-08 |
| 2011-06-30 | $1.42M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |